Sarpogrelate hydrochloride, a serotonin2A receptor antagonist, reduces albuminuria in diabetic patients with early-stage diabetic nephropathy

Methods of Enzymatic Analysis

(1975) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/58.5.1085 · Cited by 20,078 · see citing works

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N., & Shichiri, M. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01064-k · Cited by 3,079 · see citing works

Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset Diabetes

Mogensen, C. E. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402093100605 · Cited by 1,918 · see citing works

Structural-functional relationships in diabetic nephropathy.

Mauer, S. M., Steffes, M. W., Ellis, E. N., Sutherland, D. E. R., Brown, D. M., & Goetz, F. C. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111523 · Cited by 1,205 · see citing works

Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease

Barradas, M. A., Gill, D. S., Fonseca, V. A., Mikhailidis, D. P., & Dandona, P. (1988) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1988.tb01030.x · Cited by 148 · see citing works

Immunoturbidimetry of albumin and immunoglobulin G in urine.

Teppo, A.-M. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1359 · Cited by 107 · see citing works

Colorimetric methods with glucose oxidase and peroxidase

Kunst, A., Draeger, B., Ziegenhorn, J., Ziwegenhorn, J., & Ziegernhorn, J. (1988) · Cited by 105 · see citing works

Origin and Metabolism of Serotonin

Tyce, G. M. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199000163-00002 · Cited by 103 · see citing works

Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes

Małyszko, J., Urano, T., Knöfler, R., Taminato, A., Yoshimi, T., Takada, Y., & Takada, A. (1994) · Thrombosis Research · doi:10.1016/0049-3848(94)90231-3 · Cited by 87 · see citing works

Serotonin enhances the production of type IV collagen by human mesangial cells

Kasho, M., Sakai, M., Sasahara, T., Anami, Y., Matsumura, T., Takemura, T., Matsuda, H., Kobori, S., & Shichiri, M. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00114.x · Cited by 64 · see citing works

Determination of urinary 5-hydroxyindole-3-acetic acid by high-performance liquid chromatography with electrochemical detection and direct sample injection

Helander, A., Beck, O., Wennberg, M., Wikström, T., & Jacobsson, G. (1991) · Analytical Biochemistry · doi:10.1016/0003-2697(91)90134-f · Cited by 58 · see citing works

Evaluation of a fully automated high-performance liquid chromatography assay for hemoglobin A1c

Khuu, H. M., Robinson, C. A., Goolsby, K., Hardy, R. W., & Konrad, R. J. (1999) · Archives of Pathology and Laboratory Medicine · doi:10.5858/1999-123-0763-eoafah · Cited by 55 · see citing works

Identification of a rat glomerular mesangial cell mitogenic 5-HT2A receptor

Nebigil, C. G., Garnovskaya, M. N., Spurney, R. F., & Raymond, J. R. (1995) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1995.268.1.f122 · Cited by 31 · see citing works

Emerging Roles for Serotonin in Regulating Metabolism: New Implications for an Ancient Molecule

Yabut, J. M., Crane, J. D., Green, A. E., Keating, D. J., Khan, W. I., & Steinberg, G. R. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00283 · Cited by 420 · see citing works

The Influence of the Gut Microbiome on Host Metabolism Through the Regulation of Gut Hormone Release

Martin, A. M., Sun, E. W. L., Rogers, G. B., & Keating, D. J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00428 · Cited by 389 · see citing works

The diverse metabolic roles of peripheral serotonin

Martin, A. M., Young, R. L., Leong, L., Rogers, G. B., Spencer, N. J., Jessup, C. F., & Keating, D. J. (2017) · Endocrinology · doi:10.1210/en.2016-1839 · Cited by 261 · see citing works

Serotonin in the gut: Blessing or a curse

Banskota, S., Ghia, J., & Khan, W. I. (2018) · Biochimie · doi:10.1016/j.biochi.2018.06.008 · Cited by 166 · see citing works

Diabetes and nephropathy

Caramori, M. L., & Mauer, M. S. (2003) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200305000-00008 · Cited by 154 · see citing works

Altered serotonin (5-HT) 1D and 2A receptor expression may contribute to defective insulin and glucagon secretion in human type 2 diabetes

Bennet, H., Balhuizen, A., Medina, A., Nitert, M. D., Ottosson-Laakso, E., Essén, S., Spégel, P., Storm, P., Krus, U., Wierup, N., et al. (2015) · Peptides · doi:10.1016/j.peptides.2015.07.008 · Cited by 98 · see citing works

Activation of the JAK/STAT pathway in vascular smooth muscle by serotonin

Banes, A. K., Shaw, S. M., Tawfik, A. M., Patel, B., Ogbi, S. N., Fulton, D. J., & Marrero, M. B. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00385.2004 · Cited by 90 · see citing works

Augmented capacity for peripheral serotonin release in human obesity

Young, R. L., Lumsden, A. L., Martin, A. M., Schober, G., Pezos, N., Thazhath, S. S., Isaacs, N. J., Cvijanovic, N., Sun, E. W. L., Wu, T., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0047-8 · Cited by 87 · see citing works

The Regulation of Peripheral Metabolism by Gut-Derived Hormones

Sun, E. W. L., Martin, A. M., Young, R. L., & Keating, D. J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00754 · Cited by 71 · see citing works

Serotonergic regulation of insulin secretion

Cataldo, L. R., Lyons, C., Bennet, H., Artner, I., & Fex, M. (2018) · Acta Physiologica · doi:10.1111/apha.13101 · Cited by 64 · see citing works

The role of 5-HT on the cardiovascular and renal systems and the clinical potential of 5-HT modulation

Doggrell, S. A. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.5.805 · Cited by 61 · see citing works

Serotonin levels in platelet-poor plasma and whole blood in people with type 2 diabetes with chronic kidney disease

Hara, K., Hirowatari, Y., Shimura, Y., & Takahashi, H. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.06.020 · Cited by 59 · see citing works

Sarpogrelate: cardiovascular and renal clinical potential

Doggrell, S. A. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.7.865 · Cited by 54 · see citing works

Enhancement of mesenteric artery contraction to 5‐HT depends on Rho kinase and Src kinase pathways in theob/obmouse model of type 2 diabetes

Matsumoto, T., Kobayashi, T., Ishida, K., Taguchi, K., & Kamata, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00753.x · Cited by 50 · see citing works

Role of 5‐HT in the enteric nervous system and enteroendocrine cells

Spencer, N. J., & Keating, D. J. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15930 · Cited by 45 · see citing works

High Plasma 5-Hydroxyindole-3-Acetic Acid Concentrations in Subjects With Metabolic Syndrome

Fukui, M., Tanaka, M., Toda, H., Asano, M., Yamazaki, M., Hasegawa, G., Imai, S., & Nakamura, N. (2011) · Diabetes Care · doi:10.2337/dc11-1619 · Cited by 43 · see citing works

Gut mechanisms linking intestinal sweet sensing to glycemic control

Kreuch, D., Keating, D. J., Wu, T., Horowitz, M., Rayner, C. K., & Young, R. L. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00741 · Cited by 40 · see citing works

Present and Future in the Treatment of Diabetic Kidney Disease

Quiroga, B., Arroyo, D., & de Arriba, G. (2015) · Journal of Diabetes Research · doi:10.1155/2015/801348 · Cited by 40 · see citing works

Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice

Kim, D.-H., Choi, B.-H., Ku, S., Park, J. H., Oh, E., & Kwak, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153965 · Cited by 40 · see citing works

Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy

Kobayashi, S., Satoh, M., Namikoshi, T., Haruna, Y., Fujimoto, S., Arakawa, S., Komai, N., Tomita, N., Sasaki, T., & Kashihara, N. (2008) · Clinical and Experimental Nephrology · doi:10.1007/s10157-007-0011-8 · Cited by 40 · see citing works

The Role of Platelets in Diabetic Kidney Disease

Rustiasari, U. J., & Roelofs, J. J. T. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158270 · Cited by 35 · see citing works

Lactobacillus plantarum NCU116 fermented carrot juice evokes changes of metabolites in serum from type 2 diabetic rats

Li, C., Nie, S., Zhu, K.-X., Xiong, T., & Xie, M. (2015) · Food Research International · doi:10.1016/j.foodres.2015.12.025 · Cited by 35 · see citing works

Exocytosis in non‐neuronal cells

Thorn, P., Zorec, R., Rettig, J., & Keating, D. J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13602 · Cited by 33 · see citing works

The interaction between microbiome and host central nervous system: the gut-brain axis as a potential new therapeutic target in the treatment of obesity and cardiometabolic disease

Wijdeveld, M., Nieuwdorp, M., & IJzerman, R. G. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1761958 · Cited by 32 · see citing works

Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice

Lee, E. Y., Lee, E. Y., Kwon, M.-H., Kim, H. M., Kang, J. S., Kim, Y. M., Lee, E. Y., & Chung, C. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179221 · Cited by 27 · see citing works

Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease

Yang, Y., Huang, H., Xu, Z., & Duan, J. (2017) · Journal of Diabetes Research · doi:10.1155/2017/7680576 · Cited by 25 · see citing works

Diet differentially regulates enterochromaffin cell serotonin content, density and nutrient sensitivity in the mouse small and large intestine

Martin, A. M., Jones, L. A., Jessup, C. F., Sun, E. W. L., & Keating, D. J. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13869 · Cited by 25 · see citing works

Reduced Albuminuria with Sarpogrelate Is Accompanied by a Decrease in Monocyte Chemoattractant Protein-1 Levels in Type 2 Diabetes

Ogawa, S., Mori, T., Nako, K., Ishizuka, T., & Ito, S. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03450807 · Cited by 24 · see citing works

Serotonin Potentiates High-Glucose^|^ndash;Induced Endothelial Injury: the Role of Serotonin and 5-HT2A Receptors in Promoting Thrombosis in Diabetes

Yamada, K., Niki, H., Nagai, H., Nishikawa, M., & Nakagawa, H. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12009fp · Cited by 23 · see citing works

Association Of Peripheral 5-Hydroxyindole-3-Acetic Acid, A Serotonin Derivative, with Metabolic Syndrome and Low-Grade Inflammation

Afarideh, M., Behdadnia, A., Noshad, S., Mirmiranpour, H., Mousavizadeh, M., Khajeh, E., Rad, M. V., Mazaheri, T., Nakhjavani, M., & Esteghamati, A. (2015) · Endocrine Practice · doi:10.4158/ep14442.or · Cited by 23 · see citing works

Effect of the Serotonin Blocker Sarpogrelate on Circulating Interleukin-18 Levels in Patients with Diabetes and Arteriosclerosis Obliterans

Yamakawa, J.-I., Takahashi, T., Saegusa, S., Moriya, J., Itoh, T., Kusaka, K., Kawaura, K., Wang, X., & Kanda, T. (2004) · Journal of International Medical Research · doi:10.1177/147323000403200209 · Cited by 22 · see citing works

Persistent Insulin-Sensitizing Effects of Sarpogrelate Hydrochloride, a Serotonin 2A Receptor Antagonist, in Patients With Peripheral Arterial Disease

Kokubu, N., Tsuchihashi, K., Yuda, S., Hase, M., Eguchi, M., Wakabayashi, T., Hashimoto, A., Nakata, T., Miura, T., Ura, N., et al. (2006) · Circulation Journal · doi:10.1253/circj.70.1451 · Cited by 22 · see citing works

A Novel Serotonin Blocker, Sarpogrelate, Increases Circulating Adiponectin Levels in Diabetic Patients With Arteriosclerosis Obliterans

Yamakawa, J.-I., Takahashi, T., Itoh, T., Kusaka, K., Kawaura, K., Wang, X. Q., & Kanda, T. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2477 · Cited by 22 · see citing works

New insight on the mechanism of eating disorder in females based on metabolic differences of bisphenol S in female and male zebrafish

Li, Z., Wang, W., Li, J., & Ru, S. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.120820 · Cited by 20 · see citing works

Serotonin regulation of mitochondria in kidney diseases

Hurtado, K. A., Scholpa, N. E., Schnellmann, J. G., & Schnellmann, R. G. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107154 · Cited by 18 · see citing works

Role of 5-HT2 receptors in diabetes: Swertiamarin seco-iridoid glycoside might be a possible 5-HT2 receptor modulator

Sonawane, R., Deore, V., Patil, S. D., Patil, C. R., Surana, S. J., & Goyal, R. K. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.02.036 · Cited by 19 · see citing works

Serotonin 5HT2A receptor antagonism mediated anti-inflammatory and anti-fibrotic effect in adriamycin-induced CKD in rats

Kaur, G., & Krishan, P. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01826-0 · Cited by 18 · see citing works

Novel effective drugs for diabetic kidney disease? or not?

Gentile, G., Mastroluca, D., Ruggenenti, P. L., & Remuzzi, G. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2014.979151 · Cited by 17 · see citing works

Trust Your Gut: The Human Gut Microbiome in Health and Disease

AboNahas, H. H., Darwish, A. M. G., El-Kareem, H. F. A., AboNahas, Y. H., Mansour, S. A., Korra, Y. H., Sayyed, R. Z., Abdel-Azeem, A. M., & Saied, E. M. (2022) · Springer eBooks · doi:10.1007/978-981-16-1626-6_3 · Cited by 16 · see citing works

Evaluation of the effectiveness of sarpogrelate on the surrogate markers for macrovascular complications in patients with type 2 diabetes

Park, S. Y., Rhee, S. Y., Oh, S., Kwon, H., Cha, B., Lee, H. J., Lee, H. C., & Kim, Y. S. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0047 · Cited by 15 · see citing works

Increased plasma serotonin metabolite 5-hydroxyindole acetic acid concentrations are associated with impaired systolic and late diastolic forward flows during cardiac cycle and elevated resistive index at popliteal artery and renal insufficiency in type 2 diabetic patients with microalbuminuria

Saito, J., Suzuki, E., Tajima, Y., Takami, K., Horikawa, Y., & Takeda, J. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0343 · Cited by 15 · see citing works

Polymorphism of the Serotonin Transporter Gene and the Peripheral 5-Hydroxytryptamine in Obstructive Sleep Apnea: What Do We Know and What are We Looking for? A Systematic Review of the Literature

Maierean, A. D., Bordea, I. R., Sălăgean, T., Hanna, R., Alexescu, T., Chiș, A. F., & Todea, D. A. (2021) · Nature and Science of Sleep · doi:10.2147/nss.s278170 · Cited by 15 · see citing works

Glomerular transcriptomics predicts long term outcome and identifies therapeutic strategies for patients with assumed benign IgA nephropathy

Rivedal, M., Mikkelsen, H., Marti, H., Liu, L., Kiryluk, K., Knoop, T., Bjørneklett, R. O., Haaskjold, Y. L., Furriol, J., Leh, S. M., et al. (2023) · Kidney International · doi:10.1016/j.kint.2023.12.010 · Cited by 14 · see citing works

Negative correlation of urinary miR-199a-3p level with ameliorating effects of sarpogrelate and cilostazol in hypertensive diabetic nephropathy

Kim, S. K., Kim, G., Choi, B.-H., Ryu, D.-Y., Ku, S., & Kwak, M. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114391 · Cited by 14 · see citing works

Plasma serotonin is a predictor for deterioration of urinary albumin excretion in men with type 2 diabetes mellitus

Fukui, M., Shiraishi, E., Tanaka, M., Senmaru, T., Sakabe, K., Harusato, I., Hasegawa, G., & Nakamura, N. (2009) · Metabolism · doi:10.1016/j.metabol.2009.03.009 · Cited by 12 · see citing works

Understanding Serotonin 5-HT2A Receptors-regulated cellular and molecular Mechanisms of Chronic Kidney Diseases

Kaur, G., & Krishan, P. (2020) · Renal Replacement Therapy · doi:10.1186/s41100-020-00268-x · Cited by 12 · see citing works

Nephrotoxicity induced by cisplatin is primarily due to the activation of the 5-hydroxytryptamine degradation system in proximal renal tubules

Guan, J. Z., Tong, X., Zhang, Y., Xu, F., Zhang, Y., Liang, X., Jin, J., Jing, H., Guo, L., Ni, X., et al. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109662 · Cited by 12 · see citing works

Effect of a high-fat diet and chromium on hormones level and Cr retention in rats

Stępniowska, A., Tutaj, K., Juśkiewicz, J., & Ognik, K. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01677-3 · Cited by 13 · see citing works

Monoamines' role in islet cell function and type 2 diabetes risk

Roberts, F. L., Cataldo, L. R., & Fex, M. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.08.009 · Cited by 11 · see citing works

Mechanism of Sarpogrelate Action in Improving Cardiac Function in Diabetes

Goyal, R. K., Elimban, V., Xu, Y.-J., Kumamoto, H., Takeda, N., & Dhalla, N. S. (2010) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248410384708 · Cited by 11 · see citing works

BANANA PEEL FLAKES ALLEVIATE BLOOD GLUCOSE AND STRESS IN A DOSE-DEPENDENT MANNER

MELIALA, A., SUMIWI, Y. A. A., NARWIDINA, P., RINI, S. L. S., & SETYANINGSIH, W. (2020) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2020v12i8.37659 · Cited by 10 · see citing works

Beneficial Effects of Sarpogrelate Hydrochloride, a 5-ht2aReceptor Antagonist, Supplemented with Pioglitazone on Diabetic Model Mice

Iizuka, K., Hamaue, N., Machida, T., Hirafuji, M., & Tsuji, M. (2009) · Endocrine Research · doi:10.1080/07435800902889685 · Cited by 10 · see citing works

Imbalance of Renal Production Between 5-Hydroxytryptamine and Dopamine in Patients With Essential Hypertension Complicated by Microalbuminuria

Hirose, M., Tomoda, F., Koike, T., Yamazaki, H., Ohara, M., Liu, H., Kagitani, S., & Inoue, H. (2012) · American Journal of Hypertension · doi:10.1093/ajh/hps008 · Cited by 10 · see citing works

Effects of sarpogrelate on microvascular complications with type 2 diabetes

Yoo, H., Park, I., Kim, D. J., & Lee, S. (2019) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-019-00794-7 · Cited by 10 · see citing works

Current literature in diabetes

Nazlıel, B., Yetkin, İ., İrkeç, C., & Koçer, B. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.173 · Cited by 10 · see citing works

5-HT2 receptor blockade exhibits 5-HT vasodilator effects via nitric oxide, prostacyclin and ATP-sensitive potassium channels in rat renal vasculature

García‐Pedraza, J. Á., García, M., Martín, M. L., Rodríguez‐Barbero, A., & Morán, A. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.11.039 · Cited by 9 · see citing works

The prevention of contrast induced nephropathy by sarpogrelate in patients with chronic kidney disease: a study protocol for a prospective randomized controlled clinical trial

Park, K., Chung, W., Seo, J., Kim, S., Zo, J., Kim, M., & Park, Y.-B. (2010) · Trials · doi:10.1186/1745-6215-11-122 · Cited by 9 · see citing works

Tumeur carcinoïde ovarienne responsable d’une érythrose faciale permanente et de flushs au décours des coïts

Vinceneux-Talvande, B., Dorange, A., Lecouflet, M., Nezet, M. L., Kianifard, B., Maillard, H., & Duquenne, M. (2016) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2016.07.009 · Cited by 7 · see citing works

Enteroendocrine cells and gut hormones as potential targets in the crossroad of the gut-kidney axis communication

Neto, J. A. D. O. N., Yariwake, V. Y., Câmara, N. O. S., & Andrade‐Oliveira, V. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1248757 · Cited by 6 · see citing works

Relationship of Postoperative Pain and PONV after Minimally Invasive Surgery with the Serotonin Concentrations and Receptors’ Gene Polymorphisms

Ignaszak-Kaus, N., Dulęba, A. J., Mrozikiewicz, A. E., Kurzawińska, G., Różycka, A., Hauke, J., Gaca, M., Pawelczyk, L. A., Jagodziński, P. P., & Jędrzejczak, P. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11090833 · Cited by 6 · see citing works

Association Between Urinary Albumin Excretion and Plasma 5-Hydroxyindole-3-Acetic Acid Concentration in Men With Type 2 Diabetes

Fukui, M., Ose, H., Hasegawa, G., Yoshikawa, T., & Nakamura, N. (2007) · Diabetes Care · doi:10.2337/dc07-0410 · Cited by 5 · see citing works

Effect of Long-Term Diabetes on Serotonin-Mediated Contraction in Carotid Arteries from Streptozotocin-Induced Diabetic Male and Female Rats

Watanabe, S., Matsumoto, T., Ando, M., Kobayashi, S., Iguchi, M., Taguchi, K., & Kobayashi, T. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00309 · Cited by 5 · see citing works

Platelet Serotonin Levels Are Associated with Plasma Soluble Leptin Receptor Concentrations in Normoglycemic Women

Cataldo, L. R., Suazo, J., Olmos, P., Bravo, C., Galgani, J., Fex, M., Martínez, J. A., & Santos, J. (2019) · Journal of Diabetes Research · doi:10.1155/2019/2714049 · Cited by 6 · see citing works

Role of serotonin in regulation of pancreatic and mesenteric arterial function in diabetic mice

Shuai, J., Gao, Y., Chen, L., & Wang, Z. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174070 · Cited by 4 · see citing works

The Obese Brain

Carmo‐Silva, S., & Nóbrega, C. (2024) · Springer eBooks · doi:10.1007/978-3-031-62491-9_2 · Cited by 3 · see citing works

Relationship between serotonin and vascular dysfunction and the impact of 5-HT2A receptor blockade by sarpogrelate on vascular function in diabetes mellitus

Matsumoto, T., Taguchi, K., Nagano, T., Kobayashi, T., & Tanaka-Totoribe, N. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178095 · Cited by 2 · see citing works

Peripheral and central serotonin in the regulation of glucose metabolism

Serlie, M. J. M. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-444-64125-0.00045-1 · Cited by 2 · see citing works

5-Hydroxytryptamine in the Endocrine Pancreas

Fex, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-800050-2.00004-8 · Cited by 1 · see citing works

Jiao-Tai-Wan Ameliorates the Insulin Resistance and Lipid Metabolism in T2DM Rats by Regulating NeurotransmittersPreprint

Chen, J., Jing, Z., Wang, X., Chu, L., Li, Y., Li, Z., Ma, P., & Zhang, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-857847/v1

Current literature in diabetes

(2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.346

Efficacy and Safety of Sarpogrelate on Symptom Improvement in Patients with Peripheral Arterial Disease (PAD) and/or Being at Risk of PAD: A Single Arm, Multi-Centered, Open-Label Trial

Won, J. C., Song, T., Park, J. H., Kim, H.-T., Lee, K. H., Park, K. Y., Jeong, H.-S., Jeon, U., Min, K. W., & Lim, S. K. (2024) · Current Vascular Pharmacology · doi:10.2174/0115701611285172241015074050

Urinary Metabolomic Alterations Associated with Contrasting Ambient Air Pollution Exposure in Thai Adults: An Untargeted 1H-NMR Study

Zinan’dala, B., Iadnut, A., Maluwa, C., Fakfum, P., Jaikang, C., Konguthaithip, G., Kulprachakarn, K., Parklak, W., & Chuljerm, H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167193

Effects of sarpogrelate hydrochloride on renal injury of diabetic rats

Guo-hu, L. (2008) · Shanghai yixue

THE 5‐HT2 RECEPTOR ANTAGONIST SARPOGRELATE REDUCES URINARY AND PLASMA LEVELS OF THROMBOXANE A2 AND URINARY ALBUMIN EXCRETION IN NON‐INSULIN‐DEPENDENT DIABETES MELLITUS PATIENTS†

Ogawa, S., Takeuchi, K., Sugimura, K., Sato, C., Fukuda, M., Lee, R., Ito, S., & Sato, T. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1999.03056.x · Cited by 24 · see citing works

Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy

Kobayashi, S., Satoh, M., Namikoshi, T., Haruna, Y., Fujimoto, S., Arakawa, S., Komai, N., Tomita, N., Sasaki, T., & Kashihara, N. (2008) · Clinical and Experimental Nephrology · doi:10.1007/s10157-007-0011-8 · Cited by 40 · see citing works

Reduced Albuminuria with Sarpogrelate Is Accompanied by a Decrease in Monocyte Chemoattractant Protein-1 Levels in Type 2 Diabetes

Ogawa, S., Mori, T., Nako, K., Ishizuka, T., & Ito, S. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03450807 · Cited by 24 · see citing works

Therapeutic Effect of Sarpogrelate, a New 5-Hydroxytryptamine Receptor 2A Antagonist, on Diabetic Nephropathy and Neuropathy

Ishimura, E., Nishizawà, Y., Emoto, M., Shoji, T., Inaba, M., Kawagishi, T., & Morii, H. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000190175 · Cited by 12 · see citing works